FindTrial
Sign In

monoclonal antibody SGN-30

BIOLOGICAL2 trials

Sponsors

National Cancer Institute (NCI)

Conditions

Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin LymphomaAdult Nodular Sclerosis Hodgkin LymphomaAnaplastic Large Cell LymphomaRecurrent Adult Hodgkin LymphomaRecurrent Childhood Anaplastic Large Cell Lymphoma

Phase 1

Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma
TerminatedNCT00354107
National Cancer Institute (NCI)Anaplastic Large Cell Lymphoma, Recurrent Childhood Anaplastic Large Cell Lymphoma
Start: 2007-01-31End: 2010-01-31Updated: 2018-03-14

Phase 2

SGN-30 and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
CompletedNCT00337194
National Cancer Institute (NCI)Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma +2
Start: 2006-04-30End: 2014-10-31Updated: 2015-02-23